Taking Ozempic and worried about vision loss? This test can help you understand your risk.
MarketWatch· Jaimy Lee· Sep 28, 2026 · 1:36 PM
Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 7 hours ago
Elon Musk opens the door for a big SpaceX acquisition
The rocket and satellite-internet company is looking to challenge telecom giants.
MarketWatch
marketsabout 7 hours ago
Data centers run on debt. That was a problem for bonds this year — and it’s only going to get worse.
AI debt issuance this year overwhelmed investor portfolios, and has disappointed from a performance perspective. The funding need won’t get any better with Democrats in control of Congress.
MarketWatch
marketsabout 8 hours ago
Micron’s stock is dirt cheap — and that’s igniting a fierce online debate
Valuation purists see a ridiculously inexpensive stock, but some semiconductor investors say Micron’s earnings power won’t hold up.
MarketWatch